The Global Radiation Ablation Market, mainly driven by increasing aging population with high risk of chronic diseases and increasing procedures through minimal invasive surgery was valued at $3735 million in 2013 and is expected to reach $5537 million by 2018. It accounts for over 33% of the total ablation technologies market and is expected to continue enjoying a major share in radiation ablation market. In 2011, the stereotactic radiosurgery and radiotherapy accounted for the largest share of the global radiation ablation products market with 61.4%.
The report “Radiation Ablation Market forecast, 2010-2018” analyzes the market of devices by segments such as Brachytherapy, Stereotactic radiotherapy & Radiosurgery, Stereotactic Body Radiation, Image Guided Radiation Therapy, Intensity Modulated Radiation therapy, Proton Beam Therapy. The technique has been successfully used against cancers of cervix, prostate, breast and skin cancers.
In terms of volume, the stereotactic radiotherapy and radiosurgery devices accounted for the largest volume in sales in radiation ablation market.
Older population is growing in the mature markets such as Japan, U.S. and in the Western European countries. Currently, one quarter of the Japanese population is aged 65 and older. Currently, in the U.S., 40 million people are aged 65 and above and it is expected that by 2050 this number will increase to 89 million. The diseases such as cancer, cardiovascular disorders, gynecological, and orthopedic problems are on the rise. As the number of patient population will increase it will lead to increase in the procedural volume of minimally invasive surgeries, ultimately giving rise to increased demand for radiation ablation devices.
Factors such as high patient pool, growing preferences to minimally invasive surgery, geographical expansion of market players, increased government investment in healthcare facilities especially in rural areas, westernization in life style and dietary habits, increasing healthcare expenditure & improving medical insurance plans, are driving the radiation ablation devices market.
Emerging markets such as India, China, and Brazil have undergone significant economic development over the past decade. This development has also led to an increase in healthcare availability in these countries. Also, as these countries have relatively modest GDP per capita levels and highly variable healthcare systems, the need for inexpensive radiation ablation devices is emerging as an important factor. It has provided an opportunity for ablation devices companies, to have an established and growing market in these countries.
European market is challenging, as it is a heterogeneous region in terms of regulatory and reimbursement approaches, with every country having its own unique characteristics. Aging Japanese population, which is at a higher risk of developing chronic diseases such as cancer and cardiac disorders, will ultimately lead to growth in procedure volume in the future.
The report also provides an extensive competitive landscaping of companies operating in this market. The main companies operating in radiation ablation market and extensively covered in this report are Varian Medical Systems (U.S), and Elekta (Sweden).
Segment and country specific Company shares, News & Deals, M&A, segment specific pipeline products, product approvals and product recalls of the major companies have been detailed.
The market data enables you to customize the MMM assessments that meet your company’s specific needs. Customize to get comprehensive industry standards and deep dive analysis of the following parameters:
- Usage pattern (in-depth trend analysis) of products (Segment wise)
- Product Matrix which gives a detailed comparison of product portfolio of each company mapped at country and sub segment level
- End-user Adoption rate analysis of the products (Segment wise and Country wise)
- Comprehensive coverage of Product approvals, Pipeline products and Product recalls
- Country specific Prevalence of cancer, cardiovascular disorders, gynecological, and orthopedic disorders.
- Country specific Patient pool of cancer, cardiovascular disorders, gynecological, and orthopedic disorders.
- Disease progression (Pattern analysis)
Surgeons/Physicians Perception Analysis
- Fast turn-around analysis of Surgeons response to market events and trends
- Surgeons opinion about products from different companies
- Surgeons qualitative inputs on epidemiology date
Brand/Product Perception Matrix
- Comprehensive study of customers perception and behavior through our inbuilt social connect tool checking the virality and tonality of blogs
- Analysis of overall brand usage and familiarity and brand advocacy distribution (Detractor/Neutral/Familiar)
1.1 Objective of the study
1.2 Market Definitions
1.3 Market Segmentation & Aspects Covered
1.4 Research Methodology
1.4.1 Assumptions (Market Size, Forecast, etc)
2 Executive Summary
3 Market Overview
Please fill in the form below to receive a free copy of the Summary of this Report
Please visit http://www.micromarketmonitor.com/custom-research-services.html to specify your custom Research Requirement
Americas Radiation Ablation
The American Radiation Ablation Market, mainly driven by growing aging population, with increasing incidence, and prevalence of chronic diseases such as cancer and cardiovascular disorders, rapid acceptance of new medical technology, and well covered reimbursement system. The main companies operating in radiation ablation market and extensively covered in this report are Varian Medical Systems (U.S), and Elekta (Sweden).
Asia-Pacific Radiation Ablation
The Asia-Pacific Radiation Ablation Market was pegged at $559 million in 2013 and expected to be $899 million by 2018. It accounts for over 33% of the total ablation technologies market and expected to continue enjoying a major share in Radiation Ablation market. The main companies operating in Asia-Pacific radiation ablation market and extensively covered in this report are Varian Medical Systems (U.S), and Elekta (Sweden).
European Radiation Ablation
The European Radiation Ablation Market was pegged at $864 million in 2013 and expected to be $1223 million by 2018. The main companies operating in European radiation ablation devices market and extensively covered in this report are Varian Medical Systems (U.S), and Elekta (Sweden).